Països Baixos - neerlandès - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

meditrina ltd, pharmaceutical company 117 iraklitou straat 15238 athene (griekenland) - letrozol 2,5 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; lactose 1-water ; macrogol 8000 ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; lactose 1-water ; macrogol 8000 ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; lactose 1-water ; macrogol 8000 ; magnesiumstearaat (e 470b) ; maÏszetmeel, gepregelatineerd ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - letrozole

Països Baixos - neerlandès - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

s.c. rompharm company s.r.l. eroilor street, no. 1a 075100 otopeni (roemeniË) - travoprost 40 µg/ml - oogdruppels, oplossing - boorzuur (e 284) ; macrogolglycerolhydroxystearaat ; mannitol (d-) (e 421) ; natriumchloride ; natriumhydroxide (e 524) ; polyquaternium-1 ; propyleenglycol (e 1520) 7,5 mg/ml ; water, gezuiverd ; zoutzuur (e 507), - travoprost

Països Baixos - neerlandès - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

zaklady farmaceutyczne polpharma joint-stock company pelplinska 19 83 200 starograd gdanski (polen) - travoprost - oogdruppels, oplossing - benzalkoniumchloride ; boorzuur (e 284) ; castorolie, gehydreerd ; dinatriumedetaat 2-water ; mannitol (d-) (e 421) ; natriumhydroxide (e 524) ; trometamol ; water, gezuiverd ; zoutzuur (e 507), - travoprost

Països Baixos - neerlandès - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

s.c. rompharm company s.r.l. eroilor street, no. 1a 075100 otopeni (roemeniË) - bimatoprost 0,3 mg/ml ; timololmaleaat 6,8 mg/ml samenstelling overeenkomend met ; timolol 0-water 5 mg/ml - oogdruppels, oplossing - benzalkoniumchloride ; citroenzuur 1-water (e 330) ; dinatriumwaterstoffosfaat 7-water (e 339) ; natriumchloride ; natriumhydroxide (e 524) ; water, gezuiverd ; zoutzuur (e 507), - timolol, combinations

Bèlgica - neerlandès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva santé animale - pyrantelembonaat 230 mg" - poeder voor gebruik in drinkwater - 10 mg/g - broomhexinehydrochloride 10 mg/g - praziquantel, combinations - rund; varken; pluimvee

Unió Europea - neerlandès - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccins - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Unió Europea - neerlandès - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologicals voor aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Unió Europea - neerlandès - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologicals voor suidae - varkens (voor de mesterij) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Unió Europea - neerlandès - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratoire syncytiële virusinfecties - vaccins - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. het gebruik van dit vaccin moet gebeuren in overeenstemming met officiële aanbevelingen.

Unió Europea - neerlandès - EMA (European Medicines Agency)

zoetis belgium sa - sevofluraan - anesthetica, algemene - dogs; cats - voor de inductie en het behoud van anesthesie bij honden en katten.